ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

Senate confirms Crawford as FDA commissioner.

July 22, 2005

In Brief: Bogardus Heads ASTRO, Million President Elect; Woods Named Chief of NIC Contracts Review

October 27, 1989

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997